Sorry, you need to enable JavaScript to visit this website.

SYMTUZA® Coverage | SYMTUZA® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) HCP

Coverage In Your Area

Coverage for Patients Living With HIV in Washington-Arlington-Alexandria, DC-VA-MD-WV

Arrow icon

92% of Commercially Insured Patients Have Coverage for SYMTUZA®¹*

Plan Status
Aetna Preferred Specialty
National Plan Preferred
CareFirst BlueCross BlueShield Preferred
Regional Plan Preferred
State Employees of Maryland Contact Plan

$0 per Prescription Fill
Janssen CarePath Savings Program for SYMTUZA®

Your eligible commercial patients pay as little as $0 per prescription fill for their SYMTUZA® medication. There is a limit to savings each year. Patients may participate without sharing their income information. See program requirements.

* This percentage may not represent 100% of formulary lives due to data limitations.

Collected in 04/22 and may change.

This information is not a promise of coverage or payment. It is not intended to give reimbursement advice or increase reimbursement by any payer. Legal requirements and plan information can be updated frequently. Contact the plan for more information about current coverage, reimbursement policies, restrictions, or requirements that may apply.

Reference: Source: Managed Markets Insight and Technology, LLC, a trademark of MMIT, as of 04/22.  2.